Ignite Creation Date:
2024-05-06 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04715048
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-12-14
First Post:
2021-01-10
Brief Title:
Split-Face Study Comparing Botox and Jeuveau in Treating Glabellar Lines
Sponsor:
University of Southern California
Organization:
University of Southern California
Study Overview
Official Title:
Split-Face Study Comparing OnabotulinumtoxinA Botox and PrabotulinumtoxinA Jeuveau in Treating Glabellar Lines
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the efficacy and side effects of Botox and Jeuveau for glabellar lines
Detailed Description:
After being informed about the study and potential risks all patients given consent will receive Botox on one side of their face and Jueveau on the other A random number generator will generate a list of 20 combinations of 12 or 21 12 means the Botox onabotulinumtoxin A will be placed on the right side and 21 means that the Botox will be placed on the left The other side will be injected with PrabotulinumtoxinA 8-10 units will be injected into the designated glabella in 3 sites
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None